netFormulary The Pennine Acute Hospitals NHS
NHS Trust Formulary  
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.01  Expand sub section  Hypnotics and anxiolytics
04.01.01  Expand sub section  Hypnotics
Melatonin
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
M/R tablets
unlicensedCapsules (unlicensed)
unlicensed Tablets (unlicensed)
unlicensed Oral liquid (unlicensed)


Green Traffic Light applies when licensed product used in adult patients over 55

note The licensed M/R tablets can be crushed for administration in dysphagia or via enteral feeding tubes if necessary. This obviously means that they would no longer be 'modified release'. 
Link  GMMMG Recommendation: Melatonin for insomnia
   
04.01.01  Expand sub section  Benzodiazepines
Controlled Drug Temazepam
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice Tablets
Oral solution 
Nitrazepam
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets
Oral suspension 
   
04.01.01  Expand sub section  Zaleplon, Zolpidem and Zopiclone
Zopiclone
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice Tablets 
Zolpidem
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets 
   
04.01.01  Expand sub section  Chloral and derivatives to top
Chloral Hydrate 500mg in 5mL
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary  
   
04.01.01  Expand sub section  Antihistamines
Promethazine Hydrochloride
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets
Elixir
Injection 
   
04.01.02  Expand sub section  Anxiolytics
04.01.02  Expand sub section  Benzodiazepines
Diazepam
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice Tablets
Oral solution
Injection
Rectal tubes 
Lorazepam
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets
Injection 
   
Oxazepam
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary  
   
04.01.02  Expand sub section  Beta blockers
 note  Beta-blockers are indicated for patients with predominantly autonomic symptoms such as palpitations and tremor.
See section 2.4.
04.01.03  Expand sub section  Barbiturates to top
 ....
 Non Formulary Items
Almotriptan  (Almogran®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Alprazolam

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Controlled Drug  Amobarbital (amylobrbitone)  (Sodium Amytal)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Aspirin and metoclopramide  (MigraMax)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Controlled Drug  Butobarbital (butobarbitone)  (Soneryl)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Chloral Hydrate  (Chloral Elixir®, Paediatric, BP 2000)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cloral Betaine  (Welldorm)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Eletriptan  (Relpax)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Flurazepam  (Dalmane®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Frovatriptan

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Loprazolam

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Naratriptan  (Naramig)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paracetamol and metoclopramide  (Paramax)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Rizatriptan  (Maxalt®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Controlled Drug  Secobarbital (quinalbarbitone)  (Seconal Sodium )

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Tolfenamic Acid  (Clotam®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Zaleplon  (Sonata)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Zolmitriptan

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Drugs designated amber are suitable for shared care arrangements under a shared care protocol. Prescribing may be transferred from secondary to primary care once the patient is stabilised and agreed shared care arrangements have been established. Alternatively primary care may initiate under the supervision of secondary care if this option is given in the shared care document. It is recommended that shared care arrangements should be drawn up following local discussion and agreement by prescribing parties.   

Black

These products have been reviewed by the GM Joint Formulary Group and have been deemed not suitable for prescribing for adults in primary or secondary care within Greater Manchester. These decisions have been made on the basis of safety, efficacy and cost-effectiveness of the products.  

Green

Not used   

Green 1

Drugs designated green1 are suitable for initiation and ongoing prescribing within primary care.   

Green 2

Drugs designated green2 can be initiated by primary care following written or verbal advice from a specialist and then be subsequently safely prescribed in primary care with little or no monitoring required.  

Green 3

Drugs designated green3 are suitable for on-going prescribing within primary care after specialist initiation and an initial review (unless specified) in secondary care. Little or no monitoring is required.  

Grey

Not suitable for routine prescribing but may be suitable for a defined patient population. Whilst prescribers should think very carefully before prescribing or recommending any of the products on the grey list, there may be exceptional instances when the use of one of these products is necessary for a particular patient.   

Red

Drugs designated red are considered to be specialist medicines and prescribing responsibility for these medicines should normally remain with the consultant or specialist clinician. These drugs should not be initiated or prescribed in primary care. It is recommended that the supply of these specialist medicines should be organised via the hospital pharmacy, this may include arranging for supply via a home care company.   

netFormulary